Active ingredientLimaprostCat. No. P-L064-001CAS 74397-12-9Family · Pharmaceutical analytical standards
Limaprost
An oral prostaglandin E1 derivative that improves blood circulation, approved in Japan in 1988 for ulcers, pain and coldness of the extremities in thromboangiitis obliterans and, since 2001, for lumbar spinal canal stenosis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?In lumbar stenosis it works by increasing blood flow to the cauda equina, the bundle of nerve roots at the base of the spine whose Latin name means 'horse's tail'.
Go to the active ingredient →Active ingredientLimaprostCat. No. P-L064-001CAS 74397-12-9
Isotopically labelledLimaprost-d3Cat. No. P-L064-002CAS 1263190-37-9
Impurity11-Deoxy LimaprostCat. No. P-L064-003CAS 853998-93-3
Impurity15-keto LimaprostCat. No. P-L064-004
Impurity17-epi LimaprostCat. No. P-L064-005CAS 75554-85-7
Impurity8-epi LimaprostCat. No. P-L064-006
ImpurityLimaprost Impurity 1Cat. No. P-L064-007
ImpurityLimaprost Impurity 2Cat. No. P-L064-008
ImpurityLimaprost Impurity 3Cat. No. P-L064-009
ImpurityLimaprost Impurity 4Cat. No. P-L064-010
ImpurityLimaprost Impurity 5Cat. No. P-L064-011
ImpurityLimaprost Impurity 6Cat. No. P-L064-012
ImpurityLimaprost Impurity 7Cat. No. P-L064-013
ImpurityLimaprost Impurity 8Cat. No. P-L064-014
ImpurityLimaprost Impurity 9Cat. No. P-L064-015
ImpurityLimaprost Impurity 10Cat. No. P-L064-016
ImpurityLimaprost Impurity 11Cat. No. P-L064-017No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.